ZBTB16 and acute promyelocytic leukemia: To date, 20 partners have been identified (Table 1), with the most common and studied PLZF [t(11;17)(11q23;q21)], also known as ZBTB16, which is estimated to account for 1% of all cases presenting with APL-like features [18,24,25,26,27].